Clinical Trial Update: Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ALN-PCSSC treatment on LDL-C in patients with atherosclerotic cardiovascular disease and familial hypercholesterolemia; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Familial Hypercholesterolemia

Drugs mentioned

• ALN-PCSSC

Snippet

Sponsor: The Medicines Company | Conditions: Atherosclerotic Cardiovascular Disease, Familial Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2019-05-17